-
1.发明授权
公开(公告)号：EP1372728B1
公开(公告)日：2013-02-20
申请号：EP02704908.9
申请日：2002-03-07
申请人： Aker Biomarine ASA
IPC分类号： A61K47/12 , A61K31/231 , A61K47/14 , A61K9/107 , A61K9/48 , A61K31/7048 , A61K38/13 , A61K31/355 , A61K9/00
CPC分类号： A61K31/201 , A61K9/0019 , A61K9/0095 , A61K9/1075 , A61K9/4858 , A61K31/231 , A61K47/12 , A61K47/14
-
公开(公告)号：EP2400956A1
公开(公告)日：2012-01-04
申请号：EP10712494.3
申请日：2010-02-25
申请人： Aker Biomarine ASA
发明人： TILSETH, Snorre , HOEM, Nils
CPC分类号： A61K35/612 , A23L17/40 , A23L33/115 , A23L33/17 , A23P10/28 , A61K9/2009 , A61K9/2054 , A61K9/2866 , A61K31/122 , A61K31/685 , A61K2300/00
摘要： A new method for krill meal production has been developed using a two step cooking process. In the first step the proteins and phospholipids are removed from the krill and precipitated as a coagulum. In the second stage the krill without phospholipids are cooked. Following this, residual fat and astaxanthin are removed from the krill using mechanical separation methods. A novel krill meal product with superior nutritional and technical properties is prepared.
-
3.发明公开METHODS OF USING KRILL OIL TO TREAT RISK FACTORS FOR METABOLIC DISORDERS AND OBESITY 审中-公开使用磷虾油的用于风险因素的代谢紊乱和肥胖的处理方法
公开(公告)号：EP2435055A2
公开(公告)日：2012-04-04
申请号：EP10740706.6
申请日：2010-05-28
申请人： Aker Biomarine ASA
发明人： BRUHEIM, Inge , TILSETH, Snorre , COHN, Jeffrey , GRIINARI, Mikko , BANNI, Sebastiano , MANCINELLI, Daniele , HOEM, Nils , VIK, Hogne
IPC分类号： A61K35/56
CPC分类号： A61K35/612
摘要： This invention discloses methods of using krill oil and compositions comprising krill oil to treat risk factors for metabolic, cardiovascular, and inflammatory disorders. The present invention also relates to methods of using compositions comprising krill oil to modulate biological processes selected from the group consisting of glucose metabolism, lipid biosynthesis, fatty acid metabolism, cholesterol biosynthesis, and the mitochondrial respiratory chain. The present invention further includes pharmaceutical and/or nutraceutical formulations made from krill oil, methods of making such formulations, and methods of administering them to treat risk factors for metabolic, cardiovascular, and inflammatory disorders.
-
公开(公告)号：EP2190298A2
公开(公告)日：2010-06-02
申请号：EP08788481.3
申请日：2008-08-29
发明人： ØISTEIN, Høstmark , SNORRE, Tilseth
CPC分类号： C11B1/10 , A23D9/013 , A23K10/22 , A23K20/158 , A23K20/179 , A23K50/80 , A23L17/40 , A23L33/115 , A23L33/17 , A23V2002/00 , A61K31/122 , A61K31/133 , A61K31/198 , A61K31/202 , A61K31/575 , A61K31/685 , A61K35/612 , C07F9/103 , C11B1/06 , Y02A40/818
摘要： The present invention relates to a krill composition comprising from about 0.01 to about 200 mg/kg astaxanthin, from about 45% to about 65% fat w/w, and about 20% to 50% protein w/w, wherein said fat comprises omega-3 fatty acid residues
-
公开(公告)号：EP2144618A1
公开(公告)日：2010-01-20
申请号：EP08718910.6
申请日：2008-03-28
申请人： Aker Biomarine ASA
发明人： BRUHEIM, Inge , GRIINARI, Mikko , TILSETH, Snorre , BANNI, Sebastiano , COHN, Jeffrey , MANCINELLI, Daniele
IPC分类号： A61K35/60
CPC分类号： A61K35/612 , A23L33/115 , A23V2002/00 , A61K9/0053 , A61K9/48 , A61K9/4825 , A61K9/4858 , A61K31/122 , A61K31/20 , A61K31/202 , A61K31/215 , A61K31/23 , A61K31/235 , A61K31/575 , A61K31/683 , A61K31/685 , A61K45/06 , C11B3/006 , A61K2300/00
摘要： This invention discloses new krill oil compositions characterized by having high amounts of phospholipids, astaxanthin esters and/or omega-3 contents. The krill oils are obtained from krill meal using supercritical fluid extraction in a two stage process. Stage 1 removes the neutral lipid by extracting with neat supercritical CO 2 or CO2 plus approximately 5% of a cosolvent. Stage 2 extract the actual krill oils by using supercritical CO 2 in combination with approximately 20% ethanol. The krill oil materials obatined are compared with commercially available krill oil and found to be more bioeffective in a number of areas such as anti-inflammation, anti-oxidant effects, improving insulin resistances and improving blood lipid profile.
-
公开(公告)号：EP1546295B1
公开(公告)日：2015-07-29
申请号：EP03758523.9
申请日：2003-09-24
申请人： Aker Biomarine ASA
CPC分类号： C07C51/09 , C07C67/333 , C07C57/03 , C07C69/587
-
公开(公告)号：EP2144618B1
公开(公告)日：2013-05-15
申请号：EP08718910.6
申请日：2008-03-28
申请人： Aker Biomarine ASA
发明人： BRUHEIM, Inge , GRIINARI, Mikko , TILSETH, Snorre , BANNI, Sebastiano , COHN, Jeffrey , MANCINELLI, Daniele
IPC分类号： A61K35/56 , A61K31/122 , A61K31/685 , A61K35/60
CPC分类号： A61K35/612 , A23L33/115 , A23V2002/00 , A61K9/0053 , A61K9/48 , A61K9/4825 , A61K9/4858 , A61K31/122 , A61K31/20 , A61K31/202 , A61K31/215 , A61K31/23 , A61K31/235 , A61K31/575 , A61K31/683 , A61K31/685 , A61K45/06 , C11B3/006 , A61K2300/00
摘要： This invention discloses new krill oil compositions characterized by having high amounts of phospholipids, astaxanthin esters and/or omega-3 contents. The krill oils are obtained from krill meal using supercritical fluid extraction in a two stage process. Stage 1 removes the neutral lipid by extracting with neat supercritical CO 2 or CO2 plus approximately 5% of a cosolvent. Stage 2 extract the actual krill oils by using supercritical CO 2 in combination with approximately 20% ethanol. The krill oil materials obatined are compared with commercially available krill oil and found to be more bioeffective in a number of areas such as anti-inflammation, anti-oxidant effects, improving insulin resistances and improving blood lipid profile.
-
公开(公告)号：EP1456330B1
公开(公告)日：2010-01-27
申请号：EP02788328.9
申请日：2002-11-19
申请人： Aker Biomarine ASA
发明人： SAEBO, Asgeir , KLAVENESS, Jo
-
-
-
-
-
-
-
搜索结果
8 条记录 (耗时 0.011 秒)
